| Not Yet Recruiting | Comparison of the Effect on Anxiety of Combining Hypnosis and Aromatherapy Through Olfactory Anchoring Versus NCT07444255 | University Hospital, Strasbourg, France | N/A |
| Recruiting | Effects of Ketone Supplementation on Alcohol Withdrawal and Brain Metabolism in Alcohol Use Disorder NCT06559995 | University of Pennsylvania | Phase 2 / Phase 3 |
| Recruiting | Use of tAN® in Alcohol Withdrawal Management NCT06771037 | Erin Deneke | N/A |
| Recruiting | Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool NCT06618755 | University Hospital, Montpellier | N/A |
| Recruiting | Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS) NCT06675539 | Etablissement Public de Santé Barthélemy Durand | — |
| Enrolling By Invitation | Effects of Ketone Supplementation on Acute Alcohol Withdrawal NCT06173973 | University of Pennsylvania | Phase 2 / Phase 3 |
| Withdrawn | Using Transcutaneous Auricular Vagus Nerve Stimulation to Treat Acute Alcohol Withdrawal NCT04159909 | Northwell Health | N/A |
| Completed | Study of Exploratory Plasmatic Markers of Alcohol Withdrawal NCT05216705 | Institut National de la Santé Et de la Recherche Médicale, France | — |
| Enrolling By Invitation | Safety & Efficacy of Baclofen for Alcohol Withdrawal in Chronic Liver Disease With Active Alcohol Consumption NCT06840652 | Corporacion Parc Tauli | — |
| Recruiting | Bright Light Therapy During Residential Alcohol Withdrawal NCT06878287 | Centre Hospitalier St Anne | N/A |
| Completed | Metabolism of Chlordiazepoxide in the Treatment of Alcohol Withdrawal Symptoms NCT05563350 | University Hospital Bispebjerg and Frederiksberg | — |
| Unknown | Riboflavin for Glutamate Reduction in Alcohol Withdrawal NCT04232800 | Oregon Health and Science University | Phase 2 |
| Completed | Digitally Assisted Recovery Coach NCT05393544 | Brigham and Women's Hospital | N/A |
| Completed | Remote Treatment of Alcohol Withdrawal NCT04858490 | Centre for Addiction and Mental Health | N/A |
| Unknown | Evaluation of Bilateral HF-rTMS on Abstinence in Alcohol Use Disorder Patients With Executive Dysfunction NCT04997330 | Assistance Publique - Hôpitaux de Paris | N/A |
| Recruiting | Prazosin for Alcohol Use Disorder With Withdrawal Symptoms NCT04793685 | Yale University | Phase 2 |
| Terminated | Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome NCT03586089 | Unity Health Toronto | N/A |
| Unknown | Impact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD) NCT04876443 | King's College Hospital NHS Trust | — |
| Unknown | Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit NCT04156464 | OSF Healthcare System | Phase 4 |
| Unknown | Does a Ketogenic Dietary Supplement Reduce Alcohol Withdrawal Symptoms in Humans? NCT03878225 | Anders Fink-Jensen, MD, DMSci | N/A |
| Unknown | Cannabidiol (CBD) for the Treatment of Alcohol Withdrawal NCT04205682 | South West Sydney Local Health District | EARLY_Phase 1 |
| Completed | The Effect of Self-Forgiveness on Self-Stigma in Addiction. NCT03971097 | University of Pittsburgh | N/A |
| Completed | NCARE, Transition to Recovery NCT03737864 | University of Colorado, Denver | N/A |
| Completed | Auricular Vagal Stimulation in Alcohol Craving NCT05131334 | Medical University of Vienna | N/A |
| Unknown | Osteopathic Treatment to Alcohol Withdrawal Syndrome NCT03916939 | Centre Hospitalier Intercommunal Creteil | N/A |
| Withdrawn | Ketamine vs. Placebo as Adjunctive Therapies for Severe Alcohol Withdrawal NCT02823977 | University of Colorado, Denver | Phase 4 |
| Completed | Alcohol: Thiamine and or Magnesium 1 NCT03466528 | Glasgow Royal Infirmary | Phase 2 / Phase 3 |
| Unknown | Baclofen in Managing Acute Alcohol Withdrawal NCT03293017 | Universitair Ziekenhuis Brussel | Phase 4 |
| Completed | Liver Stiffness Measurement in Alcohol-dependent Subjects in Relation to Abstinence After Withdrawal NCT02202148 | Centre Hospitalier Esquirol | — |
| Completed | Observational Study on Patients With Baclofen Treatment for Alcohol-dependence in France NCT02835365 | Centre Hospitalier Intercommunal Creteil | — |
| Completed | Gabapentin for Alcohol Relapse Prevention NCT02349477 | Medical University of South Carolina | Phase 2 |
| Terminated | Preventing Alcohol Withdrawal With Oral Baclofen NCT01937364 | Essentia Health | Phase 2 |
| Completed | Family Based Prevention of Alcohol and Risky Sex for Older Teens NCT03521115 | Pacific Institute for Research and Evaluation | N/A |
| Completed | Oxytocin Treatment of Alcohol Dependence NCT02275611 | University of North Carolina, Chapel Hill | Phase 2 |
| Completed | Oxytocin Treatment of Alcohol Withdrawal NCT01212185 | University of North Carolina, Chapel Hill | Phase 1 |
| Completed | Phenobarbital for Acute Alcohol Withdrawal NCT01184417 | Jonathan Rosenson | N/A |
| Completed | Gabapentin vs Chlordiazepoxide for Ambulatory Alcohol Withdrawal NCT01573052 | VA Salt Lake City Health Care System | Phase 4 |
| Completed | Outpatient Treatment of Alcohol Withdrawal Syndrome NCT00136617 | Hvidovre University Hospital | Phase 3 |
| Completed | A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal NCT00523185 | Stanford University | N/A |